Experts say the term polycystic ovary syndrome (PCOS) does not accurately reflect the condition and has long led to patient confusion.A global consensus process involving patients and clinicians landed on what they say is a more accurate term: polyendocrine metabolic ovarian syndrome (PMOS).The name change will be rolled out over the next 3 years.
Polycystic ovary syndrome (PCOS) now has a new name that experts say more accurately reflects the condition: polyendocrine metabolic ovarian syndrome (PMOS).
The change comes after an extensive global consensus process involving patients with the condition and multidisciplinary healthcare providers around the world, reported Helena Teede, MD, PhD, of the Centre for Health Research and Implementation at Monash University in Melbourne, Australia, and colleagues.
By avoiding misleading references to ovarian cysts and accurately reflecting the condition's diverse and multisystem features, the goal is that the new name will increase awareness, enhance diagnosis, and improve care quality and patient satisfaction, the authors said in a health policy initiative in The Lancet.
"This change was driven with and for those affected by the condition and we are proud to have arrived at a new name that finally accurately reflects the complexity of the condition," Teede said in a press release.
